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Second Department of Surgery, Faculty of Medicine, Tottori University, Yonago 683-0826,
Japan
The aims of this study were i) to test the effects of protein kinase C (PKC) activation on
the intracellular Ca2+ concentration of rat cardiomyocytes during chemical hypoxia-
reoxygenation, ii) to determine the contribution of the sarcoplasmic reticulum (SR)
and the Na+-Ca2+ exchange on the regulation of intracellular Ca2+ following PKC
activation and iii) to test the role of PKC-dependent intracellular pH changes in
intracellular Ca2+ regulation.  We used the isolated adult rat cardiomyocyte perfusion
model.  Cardiomyocytes were loaded with the Ca2+-fluorescent probe Fluo-3 and the
pH-fluorescent probe SNARF1.  Cells were subjected to 50 min of glucose-free and
NaCN chemical hypoxia followed by 30 min of simulated reoxygenation.  The activation
of PKC significantly inhibited the hypoxia-induced increase of Fluo-3 fluorescent
intensity (control; 692 –  100% and activated PKC; 322 –  43%:  P < 0.05).  This inhibitory
effect was not affected by the inhibition of the SR Ca2+ uptake induced by thapsigargin,
but was cancelled by the inhibition of the Na+-Ca2+ exchange with dichlorobenzamil
(thapsigargin 337 –  47%; dichlorobenzamil 609 –  100%).  PKC activation also attenuated
the decrease in intracellular pH during chemical hypoxia, even in the presence of the
Na+-H+ exchange inhibitor amiloride (control; 6.54 –  0.02, PKC; 6.72 –  0.03, PKC +
amiloride; 6.73 –  0.03).  We concluded that the PKC attenuation of Ca2+ overloading to
rat cardiomyocytes during chemical hypoxia-reoxygenation does not depend on the
Ca2+ uptake by the SR, but does require a Na+-Ca2+ exchange.  Since PKC attenuated
the increasing intracellular H+ during chemical hypoxia, a low H+ concentration may
be important for the maintenance of Ca2+ extrusion via the Na+-Ca2+ exchange.
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Ischemic preconditioning reduces myocardial
injury induced by sustained ischemia-reperfu-
sion, with preservation of myocardial function
and infarct size reduction.  Previous findings
suggest that the activation of protein kinase C
(PKC) plays a role in the cardioprotective effect
of ischemic preconditioning (Liu et al., 1994; Li
and Kloner, 1995; Kitakaze et al., 1996).  PKC
activation by Ca2+ or pharmacologic agents
mimics ischemic preconditioning (Miyawaki
and Ashraf, 1977; Armstrong and Ganote,
1994; Tsuchida et al., 1994; Miyawaki et al.,
1996).  It has been proposed that PKC attenu-
ates an increase in intracellular Ca2+ concentra-
tion during ischemia/reperfusion via i) intra-
cellular alkalization (MacLeod and Harding,
1991), ii) activation of the sarcoplasmic reticu-
lum (SR) calcium pump (Movesesian et al.,
1984), iii) modification of the Na+-Ca2+ ex-
change (Steenbergen et al., 1993) and iv) inhib-
Abbreviations: amil, amiloride; [Ca2+]i, intracellular Ca2+ concentration; %[Ca2+]i,percentage of the pre-
ischemic fluorescene intensity; DCB, dichlorobenzamil; Fluo-3, Fluo-3 acetoxymethylester; %L, percentage
of the prehypoxic length; PKC, protein kinase C; pHin, intracellular pH; PMA, phorbol 12-myristate 13-
acetate; SNARF1, SNARF1 acetoxymethylester; SR, sarcoplasmic reticulum;thaps, thapsigargin
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ition of the L-type Ca2+ channel (Leatherman et
al., 1987; Zheng et al., 1992).  However, the
precise mechanism underlying the cardiopro-
tection afforded by PKC activation is unknown.
The present study i) examined how PKC
affects the intracellular Ca2+ concentration
([Ca2+]i) and cell length of isolated rat cardio-
myocytes during chemical hypoxia-reoxygena-
tion, ii) tested whether the SR and Na+-Ca2+
exchanger on the sarcolemma contribute to the
attenuation of Ca2+ overloading during ische-
mia under the activation of PKC and iii) exa-
mined how PKC affects intracellular pH (pHin)
and the regulation of the intracellular Ca2+
during chemical hypoxia-reoxygenation.
Materials and Methods
Isolation of rat cardiomyocytes
Ventricular myocytes were isolated from adult
rat hearts by enzymatic dissociation (Satoh et
al., 1994; Siegmund et al., 1994).  In brief, 8-
week-old male Wistar rats weighing 200 to 250
g were anesthetized by inhalation of diethyl
ether.  After an injection of 50 U of heparin into
the inferior vena cava, the hearts were quickly
excised and attached to a Langendorff appara-
tus.  Each heart was perfused through the coro-
nary artery with i) Ca2+-free Tyrode solution
(136.5 mmol/L NaCl, 5.4 mmol/L KCl, 0.53
mmol/L MgCl2, 5.5 mmol/L HEPES, 5.5 mmol/
L glucose, adjusted to pH 7.4 with NaOH) at
37˚C for 3 min, ii) Tyrode solution containing
collagenase type I (0.04 g/100 mL, Sigma
Chemical Co, St. Louis, MO) for 20 min and iii)
modified Kraftbruhe (KB) solution (70 mmol/L
KOH, 40 mmol/L KCL, 20 mmol/L KH2PO4, 3
mmol/L MgCl2, 50 mmol/L glutamic acid, 10
mmol/L glucose, 10 mmol/L HEPES, 0.5
mmol/L EGTA, titrated to pH 7.4 with KOH).
The ventricles were excised and minced in
modified KB solution.  The cells were filtered
through a stainless steel mesh (150 m m) and
incubated for 2 h.
The Guidelines for Animal Experimentation
at the Faculty of Medicine, Tottori University,
were followed.
Loading of Fluo-3 and SNARF1
The culture medium was changed from KB
solution to Medium 199 (GIBCO, Grand Island,
NY) containing 1% bovine serum albumin (wt/
vol), the Ca2+-selective fluorescence probe 10
m mol/L Fluo-3 acetoxymethylester (Fluo-3)
(Dojindo, Kumamoto, Japan).  Pluronic F127
[0.075% (wt/vol)] (Molecular Probes, Inc.,
Evgene, OR) was used as a detergent for cell
permeation of the dye (Satoh et al., 1994; Lopez
et al., 1996).  Cells were loaded for 30 min at
37˚C, followed by incubation for 30 min with
Tyrode solution to allow hydrolysis of the Fluo-
3.  The fluorescent pH indicator SNARF1 ace-
toxymethylester (SNARF1) (Molecular Probes)
at 10 m mol/L  was loaded in the same way as
Fluo-3 (Seksek et al., 1991; Zaguilan et al.,
1991).
Apparatus and measurement of [Ca2+]i ,
cell length and pHin
Cardiomyocytes attached to a glass-bottomed
dish (content volume 1 mL) on the stage of an
inverted conforcal laser microscope (InSIGHT,
Meridian Instruments Far East, Tokyo, Japan)
were perfused (0.6 mL/min) with Tyrode
solution.  The temperature of the dish was
maintained at 37˚C by a temperature controller
(Medical Systems Corp, NY).
The ion-selective fluorescent probes were
excited by an argon laser, at wave lengths of
488 nm for Fluo-3 and 514 nm for SNARF1.
The light emitted from the cells was monitored
by a CCD camera (Meridian Instruments) using
interference filters (530 nm for Fluo-3 and 580
nm and 644 nm for SNARF1).  Images were
recorded by a video cassette recorder (SONY,
Tokyo) at 30 frames per second.
The fluorescence intensity of Fluo-3 was
analyzed by the InSIGHT PLUS-IQ analysis
system (Meridian Instruments).  Because Fluo-
3 has no spectral shift on binding Ca2+, the abso-
lute value of [Ca2+]i can not be measured (Minta
et al., 1989; Hayashi et al., 1994).  Changes in
[Ca2+]i are expressed as the percentage of the
preischemic fluorescence intensity (%[Ca2+]i).
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The fluorescence intensity of SNARF1 was
analyzed by the InSIGHT PLUS-IQ analysis
system with a ratio of 580/644 nm.  The in situ
calibration of SNARF1 was conducted by the
nigericin-K+ method (Seksek et al., 1991;
Zaguilan et al., 1991).  The fluorescence inten-
sity ratio of 580/644 nm was converted to pHin
using a published calibration curve.
Cell length was measured from the Fluo-3
fluorescence image by the InSIGHT PLUS-IQ
analysis system, and changes in cell length are
expressed as the percentage of the prehypoxic
cell length (%L).
The %[Ca2+]i, pHin and %L were calculated
from the mean of 30 frames (1 s) at each experi-
mental point.
Experimental protocol 1
Effects of PKC activation on Ca2+ over-loading
and cell length during chemical hypoxia-
reoxygenation (Fig. 1).
Control:  Cardiomyocytes loaded with Fluo-
3 were perfused with Tyrode solution equil-
ibrated with 100% O2 for 30 min. The cells
were then subjected to chemical hypoxia for 50
min and reoxygenation for 30 min.  The chem-
ical hypoxic solution was based on Tyrode so-
lution but contained 2 mmol/L NaCN, no
glucose and a pH of 6.7.
PMA:  Cells were exposed to 0.1 m mol/L
phorbol 12-myristate 13-acetate (PMA) (Wako,
Osaka, Japan) for 5 min before normoxic perfu-
sion.  The cells were subsequently perfused
with oxygenated Tyrode solution and subjected
to chemical hypoxia-reoxygenation in the same
way as the controls.
PMA + thaps:  The procedure was similar
to the PKC group except that 100 nmol/L
thapsigargin (thaps) (Funakoshi, Tokyo) was
included in the perfusion solution administered
during chemical hypoxia (Wu and Feher, 1995;
Meldrum et al., 1996).
PMA + DCB:  The procedure was similar to
the PKC group except that 20 m mol/L 2-4-
dichlorobenzamil (DCB) (Molecular Probes)
was included in the perfusion solution admin-
istered during chemical hypoxia (Schiffman et
al., 1990; Kawada et al., 1992).
Fluo-3 signals were obtained 1 min before
Protocol 1
Control
PMA
PMA + thaps
PMA + DCB
Protocol 2
Control
PMA
PMA + amil
Normoxic perfusion Chemical hypoxia Reoxygenation
             PMA
0.1 m mol/L
thaps 100 nmol/L
DCB 2 m mol/L
amil 2 mmol/L
 –35   –30   0 50 80 (min)
Time
Fig. 1.  Schematic representation of the 2 cardiomyocyte treatment protocols.  Cells were perfused with 100%
oxygenated Tyrode solution during normoxic perfusion and reoxygenation periods.  Chemical hypoxia was
achieved by the perfusion of Tyrode solution with 2 mmol/L NaCN without glucose at pH 6.7.  In the
activated PKC group, cells were perfused with Tyrode solution with 0.1 m mol/L PMA for 5 min from –35 to
–30 min.  amil, amiloride; DCB, dichlorobenzamil; PKC, protein kinase C; PMA, phorbol 12-myristate 13-
acetate; thaps, thapsigargin.
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chemical hypoxia as prehypoxic data and for
every 5-min period during chemical hypoxia-
reoxygenation.
Experimental protocol 2
Effects of PKC activation on intracellular acido-
sis during chemical hypoxia-reoxygenation
(Fig. 1).
Control:  Cells loaded with SNARF1 under-
went the same procedure as the control group in
protocol 1.
PMA:  Cells loaded with SNARF1 underwent
the same procedure as the PMA group in protocol 1.
PMA + amil:  This procedure was similar to
that used for PMA, except that 2 mmol/L amil-
Fig. 2.  The time course of
changes in %[Ca2+]i during
chemical hypoxia-reoxygena-
tion in untreated (open circles, n
= 11) and activated PKC-treated
(closed circles, n = 11) rat car-
diomyocytes.  Data are mean –
SEM of control and PMA-
treated cells.  PKC, protein
kinase C; PMA, phorbol 12-
myristate 13-acetate.
Fig. 3.  The time course of %
changes in initial cell length
during chemical hypoxia-reoxy-
genation in untreated (open
circles, n = 11) and activated
PKC (closed circles, n = 11) rat
cardiomyocytes.  PKC, protein
kinase C; PMA, phorbol 12-
myristate 13-acetate.
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oride (amil) (an inhibitor of the Na+-H+ exchang-
er) was administered during chemical hypoxia.
The data were collected at the same point as
those for protocol 1.
Statistical analysis
All data are expressed as mean –  SEM.  The sig-
nificance of differences among groups was deter-
mined using an analysis of variance with
Fisher’s PLSD post hoc test.  Values of P < 0.05
were considered significant.  All statistical ana-
lysis was performed using the software program
StatView version J-4.5 on a Macintosh com-
puter.
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Results
Isolated cardiomyocytes
We selected the following cells, each loaded
with fluorescent dye to use as material in the
experiment:  i) cells that were rod-shaped, ii)
those with clear cross-striations and iii)
quiescent cells.  The mean initial cell length
was 106 –  3 m m (n = 42), and there were no
significant differences in cell length among
these 4 groups.  The cells which had entirely
balled up into blebbed forms with an absent
sarcomere pattern were defined as hyper-
contractured cells.
Effects of PKC activation on [Ca2+]i and
cell length
In the control and PMA groups, [Ca2+]i in-
creased significantly 25 min after the induction
of chemical hypoxia (Fig. 2).  The %[Ca2+]i
rose continuously to the end of chemical
hypoxia in both groups.  However, the increase
of [Ca2+]i in the PMA group was considerably
attenuated from 35 to 50 min of chemical hypoxia
compared with controls.  Finally, the %[Ca2+]i
of the control and PMA groups reached 692 –
100% (n = 11) and 322 –  43% (n = 11) respec-
tively in chemical hypoxia (P < 0.05) (Fig. 4).
After reoxygenation, %[Ca2+]i decreased in
both groups and reestablished preischemic
levels within 15 min.
Ischemic cell shortening (rigor shortening)
was observed 15 min after the initiation of
chemical hypoxia in both groups (Fig. 3). The
cell shapes changed rapidly from rod to square
with a length reduction to about 62% of the
initial length.  At the end of chemical hypoxia,
the %L values of the control and PMA groups
were reduced to 62.9 –  1.7% and 62.5 –  1.5%,
respectively.  In the control cells, hypercontra-
ction occurred at the initiation of reoxygena-
tion.  In contrast, hypercontraction was not ob-
served in the PMA group, and some cells slight-
ly recovered their length.  At 30 min after re-
oxygenation, the %L values of the control and
PMA groups were 40.8 –  2.6% and 61.8 –  2.1%
(P < 0.05), respectively (Fig. 5).
Fig. 5.   Cell length changes in isolated rat
cardiomyocytes treated with PMA, thaps or DCB.  In
the PMA group and the PMA + thaps group, cell
lengths were maintained compared with the controls,
but in the PMA + DCB group, the cell lengths were
not significantly different from those of the controls
at the end of reoxygenation.  *P < 0.05.  DCB, dichlor-
obenzamil; PMA, phorbol 12-myristate 13-acetate;
thaps, thapsigargin.
(%)
Control PMA PMA + PMA +
thaps DCB
1000
900
800
700
600
500
400
300
200
100
0
%
[C
a2
+ ] i
(%)
Control PMA PMA + PMA +
thaps DCB
100
90
80
70
60
50
40
30
20
10
0
%
L
Fig. 4.  Intracellular Ca2+ concentration changes in
isolated rat cardiomyocytes treated with PMA, thaps
or DCB.  The PMA group and the PMA + thaps
group showed lesser increases of %[Ca2+]i than the
controls, but the PMA + DCB group showed no sig-
nificant difference from the controls at the end of
chemical hypoxia.  *P < 0.05.  DCB, dichloro-
benzamil; PMA, phorbol 12-myristate 13-acetate;
thaps, thapsigargin.
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Contribution of SR and the Na+-Ca2+ ex-
changer
In the PMA + thaps group, the increase of
%[Ca2+]i during chemical hypoxia was attenu-
ated.  The PMA + thaps value of %[Ca2+]i at 50
min of hypoxia was 337 –  47% (n = 10), with no
significant difference between the PMA and
PMA + thaps group (Fig. 4).
The alteration of %L in the PMA + thaps
group was similar to that of the PMA group;
hypercontraction was not observed after reoxy-
genation, and the final %L was 69.4 –  1.78%,
not significantly different from the PMA group
value (Fig. 5).  These results indicate that the
effects of PKC activation were not abolished
despite the inhibition of SR Ca2+ uptake.
In the PMA + DCB group, the %[Ca2+]i at
50 min of hypoxia and final %L were 609 –
100% and 39.4 –  4.6% (n = 10), respectively.
These values were not significantly different
from those of the controls (Figs. 4 and 5).
These results suggest that the effects of PKC
activation were abolished by inhibition of the
Na+-Ca2+ exchanger.
Effects of PKC activation on pHin during
chemical hypoxia
The pHin values before chemical hypoxia in the
control, PMA and PMA + amil groups were
7.30 –  0.03 (n = 10), 7.33 –  0.02 (n = 9) and
7.25 –  0.03 (n = 9),  respectively.  In all groups,
a decrease of pHin was observed during chem-
ical hypoxia (Fig. 6).
In the PMA and PMA + amil groups, intra-
cellular acidification was significantly reduced
compared with the control group at 25 min be-
fore reoxygenation.  The final pHin values dur-
ing chemical hypoxia of the control, PMA and
PMA + amil groups were 6.54 –  0.02, 6.72 –
0.03 and 6.73 –  0.03, respectively (Fig. 6).
In the PMA + amil group, the effect of PKC
activation was observed despite inhibition of
the Na+-H+ exchanger.
Discussion
This study demonstrated that PKC activation by
PMA affects the [Ca2+]i, L and pHin of isolated
rat cardiomyocytes during chemical hypoxia.  In-
tracellular Ca2+ is a very important factor in cell
damage during ischemia-reperfusion (Smith
and Allen, 1988).  A Ca2+ overloading of car-
diomyocytes accelerates ATP depletion and
activates Ca2+-dependent enzymes, leading to
irreversible changes including hypercontraction
at reperfusion (Nicotera et al., 1989; Ladilov et
al., 1997).  The reduction of a Ca2+ overload may
thus reduce reperfusion injury, preserve cardiac
function and limit infarction size.
The results of the present study indicate that
the activation of PKC reduced the increase of
[Ca2+]i during chemical hypoxia.  This suggests
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PMA
PMA + amil
Time
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Fig. 6.  The time course of
changes in pHin during chem-
ical hypoxia-reoxygenation in
untreated rat cardiomyocytes
(open circles, n = 10 ), those
with activated PKC (closed cir-
cles, n = 9 ), and those with acti-
vated PKC and inhibited Na+-
H– exchanger (squares, n = 9 ).
amil, amiloride; PKC, protein
kinase C; PMA, phorbol 12-
myristate 13-acetate.
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that activating PKC might protect the myocar-
dium from ischemia and reperfusion injury, as
previously reported (Miyawaki and Ashraf,
1977; Armstrong and Ganote, 1994; Tsuchida
et al., 1994; Miyawaki et al., 1996).
Cell-length changes of isolated cardio-
myocytes may be useful as an index for systolic
and diastolic function of the myocardium.  We
observed that the rat cardiomyocytes shortened
to 65% of their initial length during chemical
hypoxia.  This hypoxic shortening is reversible,
and myocytes have the ability to undergo twitch
contractions if the cells have suffered no irre-
versible ischemic damage.  When the ischemic
injury was more severe, reoxygenation caused a
sudden further contraction of the cells at
reperfusion, to 36% of their initial length.
Hyper-contracted cells never recover their
length and have no contraction ability (Stern et
al., 1985).  Pathologically, hypercontraction
may prevent recovery of cardiac function.  The
lengths of the present PKC-activated cells were
maintained after reoxygenation compared with
the controls, which suggests that activated PKC
may protect myocardial function.  Meldrum and
colleagues (1996) demonstrated the effects of
activated PKC on cardiac function and the
leakage of creatinine kinase during ischemia-
reperfusion, using the Langendorff model.  Our
results support their study; we examined the
same phenomena at the cellular level.
Several mechanisms for the attenuation of
Ca2+ overload during ischemia by activated
PKC have been proposed.  Movsesian and co-
workers (1984) reported that PKC stimulates
Ca2+ uptake from cytosol by the SR.  Steenbergen
and coworkers (1993) suggested that PKC
activation modifies the Na+-Ca2+ exchanger.
Lacarda and colleagues (1988) proposed that
activated PKC inhibits the L-type Ca2+ channel.
However, the precise mechanism of how PKC
attenuates a Ca2+ overload remains uncertain.
In the present study, we tested the contribution
of Ca2+ uptake by SR and Ca2+ extrusion by the
Na+-Ca2+ exchanger under the activation of PKC.
The inhibition of Ca2+ uptake from the cyto-
sol into the SR by thapsigargin did not block the
effects of activated PKC during chemical hypo-
xia.  This result suggests that the SR did not
play an important role in the effect of PKC.
Since the SR Ca2+ pump requires ATP to func-
tion, its activation by PKC might increase ATP
consumption, and the pump would thus not
function during severe ischemic ATP depletion.
However, when the Na+-Ca2+ exchanger
was inhibited, the effects of PKC activation
were abolished.  This indicates that the attenu-
ation of a Ca2+ overload by PKC depends on the
Na+-Ca2+ exchanger.  The Na+-Ca2+ exchanger
is a passive Ca2+ transport system that is depen-
dent on the electrical membrane potential and
the intra- and/or extra-cellular concentrations of
Ca2+ and Na+.  The Na+-Ca2+ exchanger is thus
a potentially important mechanism in the
regulation of Ca2+ under the condition of severe
ATP depletion.
The activation of PKC also reduced intra-
cellular acidification during chemical hypoxia.
Meldrum and colleages (1997) and Rehring and
colleages (1996) reported that the activation of
PKC by PMA or a 1 adrenoreceptor stimulation
limits ischemic acidosis in rat hearts.  This ef-
fect was independent of the Na+-H+ exchanger,
because it occurred despite Na+-H+ exchanger
inhibition.  Macleod and Harding (1991) pro-
posed that PKC does not activate the Na+-H+
exchanger directly but rather the Na+-H+ ex-
changer function was modified by the change in
pHin.  The mechanisms underlying the reduc-
tion of intracellular acidification following
PKC activation are unknown, although Murry
and coworkers (1990) showed that precondition-
ing reduced the production of lactate,  resulting
in a drop in cytosolic pH during ischemia.
Kohmoto and colleagues (1990) and
Coravoeuf and coworkers (1981) suggested that
intracellular acidosis impairs Ca2+ extrusion via
the Na+-Ca2+ exchanger.  Intracellular H+ may
directly inhibit the Na+- Ca2+ exchanger
(Philipson et al., 1982), and may also indirectly
inhibit it by increasing the Na+ influx via the
Na+-H+ exchanger (Baker and McNaughton,
1976).  If activated PKC attenuates intracellular
acidosis by stimulation of the Na+-H+ exchang-
er, the intracellular Na+ would increase and in-
hibit the Na+-Ca2+ exchanger.  Thus, PKC may
not directly stimulate the Na+-Ca2+ exchange
but rather may inhibit it via a reduction of H+
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production.  Our present results suggest that a
reduced pHin leads to a reduced Na+ influx via
the Na+-H+ exchanger and limits increases in
[Ca2+]i by maintaining the function of the Na+-
Ca2+ exchanger.  This hypothesis is the same as
that of Steenbergen (1993), who reported
similar ionic changes using a nuclear magnetic
resonance (NMR) analysis of ischemically
preconditioned guinea pig hearts.
Since the signal transduction pathways
following PKC activation are complex, there
are other possible mechanisms for cardio-
protection from Ca2+ overload and reoxyge-
nation hypercontracture.  Ladilov and co-
workers (1997) suggested that the prevention of
the ischemic dephosphorylation of contractile
proteins reduces the susceptibility of cells to
reoxygenation hypercontracture.  The reduction
of myofilament sensitivity to calcium may be
mediated by PKC-dependent pathways and
contribute to the reduction of the susceptibility
of isolated cardiomyocytes to reoxygenation
hypercontracture.
In summary, the activation of PKC attenu-
ates the Ca2+ overload of rat cardiomyocytes
and facilitates the maintenance of cell length
during chemical hypoxia-reoxygenation.  These
effects do not depend on the Na+-H+ exchanger
or SR, but require the Na+-Ca2+ exchanger func-
tion and a reduction of intracellular acidosis.
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